Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gottfried Novacek

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Inflammatory Intestinal Diseases|June 26, 2025
Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative ColitisFlorian Grob, Isabel Häberling, Gottfried Novacek, et al.
European Journal of Clinical Investigation|October 8, 2016
Platelets Toll-like receptor-4 in Crohns diseaseWerner Schmid, Gottfried Novacek, Harald Vogelsang, et al.
Scandinavian Journal of Gastroenterology|July 27, 2021
Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's diseaseChristian Primas, Gertrud Hopf, Sieglinde Reinisch, et al.
Journal of Crohn'S & Colitis|April 2, 2011
Long-term follow-up of babies exposed to azathioprine in utero and via breastfeedingSieglinde Angelberger, Walter Reinisch, Agnes Messerschmidt, et al.
Inflammatory Bowel Diseases|October 12, 2004
Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literatureGottfried Novacek, Markus Haumer, Wolfgang Schima, et al.
Journal of Clinical Pharmacology|January 31, 2018
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard SystemAlexander Eser, Christian Primas, Sieglinde Reinisch, et al.
Wiener Klinische Wochenschrift|December 1, 2022
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Zeitschrift Fur Gastroenterologie|January 12, 2026
Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's diseaseJagoda Pokryszka, Christian Primas, Michael Stadlmann, et al.
The American Journal of Gastroenterology|June 18, 2003
Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongueWolfgang Jessner, Harald Vogelsang, Andreas Püspök, et al.
World Journal of Gastroenterology|September 30, 2006
Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's diseaseGottfried Novacek, Wolfgang Miehsler, Julia Palkovits, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Inflammatory Intestinal Diseases|June 26, 2025
Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative ColitisFlorian Grob, Isabel Häberling, Gottfried Novacek, et al.
European Journal of Clinical Investigation|October 8, 2016
Platelets Toll-like receptor-4 in Crohns diseaseWerner Schmid, Gottfried Novacek, Harald Vogelsang, et al.
Scandinavian Journal of Gastroenterology|July 27, 2021
Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's diseaseChristian Primas, Gertrud Hopf, Sieglinde Reinisch, et al.
Journal of Crohn'S & Colitis|April 2, 2011
Long-term follow-up of babies exposed to azathioprine in utero and via breastfeedingSieglinde Angelberger, Walter Reinisch, Agnes Messerschmidt, et al.
Inflammatory Bowel Diseases|October 12, 2004
Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literatureGottfried Novacek, Markus Haumer, Wolfgang Schima, et al.
Journal of Clinical Pharmacology|January 31, 2018
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard SystemAlexander Eser, Christian Primas, Sieglinde Reinisch, et al.
Wiener Klinische Wochenschrift|December 1, 2022
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Zeitschrift Fur Gastroenterologie|January 12, 2026
Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's diseaseJagoda Pokryszka, Christian Primas, Michael Stadlmann, et al.
The American Journal of Gastroenterology|June 18, 2003
Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongueWolfgang Jessner, Harald Vogelsang, Andreas Püspök, et al.
World Journal of Gastroenterology|September 30, 2006
Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's diseaseGottfried Novacek, Wolfgang Miehsler, Julia Palkovits, et al.
Pageof 7